Proven Track Record of Most Accurate Analysis
Proven Track Record
of Most Accurate Analysis
Subscribers to ZYX Short Sell Change Alert took partial profits on Acorda Therapeutics (ACOR)at $30.20 on Friday. We are holding partial position for the prices to hit our target zone. This target zone was provided to the subscribers of ZYX Short Sell Change Alert at the time of the trade entry on Acorda Therapeutics.
LinkedIn (LNKD) frenzy continues. Fundamentals do not justify buying LinkedIn at this level. LinkedIn is no Google (GOOG). Options will start trading Thursday and stock should become available for shorting after that. An analysis of the historical data of similar situations shows that shorting this stock in the near term will be a disaster. There are low risk ways to make money from LinkedIn. Here are the excerpts from my article on Seeking Alpha: LinkedIn: Overvalued, But a Dangerous Short LinkedIn (LNKD) went public Thursday, setting a frenzy on Wall Street. It was
We are taking partial profits on LTD right here at $39.22. We will leave the rest to hit our target zone.
Acorda Therapeutics (ACOR) is up due to the positive opinion on Marketing Authorization Application for its MS drug Ampyra in Europe. This approval for Acorda Therapeutics was expected. The big move in Acorda is unwarranted. We are short selling in the strength now with an average price $32.98 and will add if the stock goes higher. As a full disclosure, this alert was earlier published in ZYX Short Sell Change Alert — Real Time Feed. For stops and targets please see ZYX Short Sell Change Alert.
We are taking partial profits on Limited Brands (LTD) right here at $40.87. Please see the prior entry for details of the entry.
Limited Brands (LTD) reported earnings after the close. The earnings were below the whisper number. The projections of Limited Brands was less than the published consensus and quite a bit below the whisper numbers. The growth of Limited Brands is clearly slowing. Bounce in the stock is an opportunity to sell or short sell. We are now short from an average price of $43.09. ZYX Short Sell Change Alert — Real Time Feed has been providing actionable signals on this stock. For details of our trades please see ZYX Short Sell Change Alert.
Longtop financial (LFT) was scheduled to report earnings on May 23rd as we have previously pointed out. Longtop Financial has announced that it will not be reporting earnings on May 23rd and has not yet provided another date. It is difficult to interpret this information. Is there a serious problem? Is this simply a case of accountants getting delayed for some innocuous reason? We will keep you informed about Longtop Financial as we learn more.
Apple (AAPL) rumored to be looking at Omnivision’s (OVTI) five megapixel new chip for iPad 3. This morning we made an entry in ZYX Buy Change Alert — Real Time Feed: We are long from $12.50. Now the stock is at $33.61. Our target remains $45. This has been a very volatile stock, the volatility has not shaken us to sell our position prematurely primarily because of technological developments at the company. Our rational for holding OVTI has become public news today. OVTI introduced the OV5690, the first 5-megapixel image sensor to use OVTI’s proprietary OmniBSI-2